Oct. 28, 2024 –The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.

Sulopenem, which will now go by the commercial moniker Orlynvah, was approved by the FDA Friday to treat uncomplicated urinary tract infections (uUTIs) caused by E. coli, Klebsiella pneumoniae or ...

Researchers describe the full molecular structure of the phage DEV. DEV infects and lyses Pseudomonas aeruginosa bacteria, an opportunistic pathogen in cystic fibrosis and other diseases.

DEV infects and lyses Pseudomonas aeruginosa bacteria, an opportunistic pathogen in cystic fibrosis and other diseases. DEV is part of an experimental phage cocktail developed to eradicate P.

Consumer Reports has no financial relationship with any advertisers on this site. Urinary tract infections are common, especially, though not exclusively, in women, and the risk generally ...

The researchers examined a community of three bacterial species: Pseudomonas aeruginosa, Escherichia coli, and Enterococcus faecalis. All behave as opportunistic pathogens and are frequently isolated ...

One species, Pseudomonas aeruginosa, a versatile pathogen ... and are frequently isolated from catheter-associated urinary tract infections, so understanding how they interact could enhance ...

Introduction: Urinary tract infection (UTI) is one of the most common medical complaints in the emergency ... Twenty-one out of 72 (29.1%) had an ESBL-producing GNB. Three of 72 patients had ...

Pseudomonas aeruginosa can cause a range of infections in vulnerable individuals, including pneumonia, urinary tract infections and even sepsis. In hospital settings, this cockroach-borne bacteria ...